FDA MedWatch | Medication Safety Officers Society- MSOS

Broselow Pediatric Emergency Rainbow Tape Recall: AirLife Removes Certain Broselow Pediatric Emergency Rainbow Tapes due to Misprinted Information

Wed, 07/09/2025 - 00:00

Certain Broselow Pediatric Emergency Rainbow Tapes were manufactured with incorrect information on the tape.

Cybersecurity Vulnerabilities with Certain Patient Monitors from Contec and Epsimed: FDA Safety Communication

Wed, 07/02/2025 - 00:00

The FDA is raising awareness about cybersecurity vulnerabilities with Contec CMS8000 and Epsimed MN-120 patient monitors.

Early Alert: Infusion Pump Software Issue from Baxter

Tue, 07/01/2025 - 12:00

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program

Extended-Release Stimulants for ADHD: FDA Drug Safety Communication - FDA Requires Expanded Labeling about Weight Loss Risk in Patients Younger than 6 Years

Tue, 07/01/2025 - 00:00

The FDA is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD) - including certain formulations of amphetamine and methylphenidate - to warn about the risk of weight loss and other adverse reactions (side effects) in patients yo

Early Alert: Blood Pump Controller Issue from Abiomed

Tue, 07/01/2025 - 00:00

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program

Pages

Members Log In